🇺🇸 FDA
Patent

US 10870679

Modulation of structured polypeptide specificity

granted A61PA61P11/02A61P17/00

Quick answer

US patent 10870679 (Modulation of structured polypeptide specificity) held by BicycleRD Limited expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/02, A61P17/00, A61P17/04, A61P27/02